Earlier this year, Gribbles Pathology, a leading clinical lab testing service provider in Malaysia, undertook a rebranding exercise into Innoquest Pathology. We speak to Dr Nelson Nheu, CEO of Innoquest Pathology, on what this means for doctors and patients, and Gribbles' network of diagnostic labs. For our full range of accredited services, contact us today at: https://www.innoquest.com.my/contact/

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  technology,  wellness,  medical advances

Tags:  Innoquest Pathology,  clinical,  lab trial,  rebranding,